Craig Collard - Apr 30, 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/Kathryn Lester Attorney-in-fact for Craig Collard
Stock symbol
HRTX
Transactions as of
Apr 30, 2025
Transactions value $
$0
Form type
4
Date filed
5/2/2025, 08:23 PM
Previous filing
Apr 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Collard Craig A Chief Executive Officer, Director 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/Kathryn Lester Attorney-in-fact for Craig Collard 2025-05-02 0001363558

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Options Exercise +34.8K +8.89% 426K Apr 30, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Restricted Stock Units Options Exercise $0 -34.8K -6.25% $0.00 522K Apr 30, 2025 Common Stock 34.8K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).